Latest News
NeurologyLive® Brain Games: September 14, 2025
Advertisement Quiz|Articles|September 14, 2025 NeurologyLive® Brain Games: September 14, 2025 Author(s)Marco Meglio Test your neurology knowledge with...
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
Advertisement News|Articles|September 13, 2025 MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne Author...
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
Advertisement Commentary|Videos|September 13, 2025 DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point Author(...
Special Episode: Understanding Fremanezumab's Expanded Indication in Pediatric Migraine
Advertisement Commentary|Podcasts|September 12, 2025 Special Episode: Understanding Fremanezumab's Expanded Indication in Pediatric Migraine Author(s)...
Expanding the Alzheimer Drug Development Pipeline
Commentary|Videos|September 12, 2025 Expanding the Alzheimer Drug Development Pipeline Author(s)Sharon Cohen, MD, FRCPC In this seventh episode, Cohen...
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
Advertisement News|Articles|September 12, 2025 FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency Author(s)Mar...
Shared Decision-Making and Ethics in Complex Neurology Clinical Research: Paul Ford, PhD
Advertisement Commentary|Videos|September 12, 2025 Shared Decision-Making and Ethics in Complex Neurology Clinical Research: Paul Ford, PhD Author(s)I...
NeurologyLive® Friday 5 — September 12, 2025
Advertisement News|Articles|September 12, 2025 NeurologyLive® Friday 5 — September 12, 2025 Author(s)Isabella Ciccone, MPH Take 5 minutes to catch up...
Dual Orexin Receptor Agonists Show Lower Real-World Abuse Potential Than Traditional Insomnia Treatments
A real-world study using data from the FDA Adverse Event Reporting System (FAERS) database revealed that among several different classes of medication...
Setting Realistic Expectations for Antiamyloid Therapeutics
At the 2025 Alzheimer’s Association International Conference, held July 27-30, in Toronto, Canada, Alzheimer disease (AD) expert Sharon Cohen, MD, FRC...
NeurologyLive® Brain Games: September 14, 2025
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
Special Episode: Understanding Fremanezumab's Expanded Indication in Pediatric Migraine
Expanding the Alzheimer Drug Development Pipeline
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
Shared Decision-Making and Ethics in Complex Neurology Clinical Research: Paul Ford, PhD
NeurologyLive® Friday 5 — September 12, 2025
Dual Orexin Receptor Agonists Show Lower Real-World Abuse Potential Than Traditional Insomnia Treatments
Setting Realistic Expectations for Antiamyloid Therapeutics
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago